These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1121 related articles for article (PubMed ID: 30190063)

  • 1. Incidence, Management, and Associated Clinical Outcomes of New-Onset Atrial Fibrillation Following Transcatheter Aortic Valve Replacement: An Analysis From the STS/ACC TVT Registry.
    Vora AN; Dai D; Matsuoka R; Harrison JK; Hughes GC; Sherwood MW; Piccini JP; Bhardwaj B; Lopes RD; Cohen D; Holmes DR; Thourani VH; Peterson E; Kirtane A; Kapadia S; Vemulapalli S
    JACC Cardiovasc Interv; 2018 Sep; 11(17):1746-1756. PubMed ID: 30190063
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of Direct Oral Anticoagulant and Outcomes in Patients With Atrial Fibrillation after Transcatheter Aortic Valve Replacement: Insights From the STS/ACC TVT Registry.
    Tanawuttiwat T; Stebbins A; Marquis-Gravel G; Vemulapalli S; Kosinski AS; Cheng A
    J Am Heart Assoc; 2022 Jan; 11(1):e023561. PubMed ID: 34970918
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of Pre-Existing and New-Onset Atrial Fibrillation on Outcomes After Transcatheter Aortic Valve Replacement.
    Mentias A; Saad M; Girotra S; Desai M; Elbadawi A; Briasoulis A; Alvarez P; Alqasrawi M; Giudici M; Panaich S; Horwitz PA; Jneid H; Kapadia S; Vaughan Sarrazin M
    JACC Cardiovasc Interv; 2019 Nov; 12(21):2119-2129. PubMed ID: 31629743
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Prevalence and Impact of Atrial Fibrillation on 1-Year Outcomes in Patients Undergoing Transcatheter Mitral Valve Repair: Results From the Society of Thoracic Surgeons/American College of Cardiology Transcatheter Valve Therapy Registry.
    Arora S; Vemulapalli S; Stebbins A; Ramm CJ; Kosinski AS; Sorajja P; Piccini JP; Cavender MA; Vavalle JP
    JACC Cardiovasc Interv; 2019 Mar; 12(6):569-578. PubMed ID: 30898255
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Warfarin and Antiplatelet Therapy Versus Warfarin Alone for Treating Patients With Atrial Fibrillation Undergoing Transcatheter Aortic Valve Replacement.
    Abdul-Jawad Altisent O; Durand E; Muñoz-García AJ; Nombela-Franco L; Cheema A; Kefer J; Gutierrez E; Benítez LM; Amat-Santos IJ; Serra V; Eltchaninoff H; Alnasser SM; Elízaga J; Dager A; García Del Blanco B; Ortas-Nadal Mdel R; Marsal JR; Campelo-Parada F; Regueiro A; Del Trigo M; Dumont E; Puri R; Rodés-Cabau J
    JACC Cardiovasc Interv; 2016 Aug; 9(16):1706-17. PubMed ID: 27539691
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical outcomes at 1 year following transcatheter aortic valve replacement.
    Holmes DR; Brennan JM; Rumsfeld JS; Dai D; O'Brien SM; Vemulapalli S; Edwards FH; Carroll J; Shahian D; Grover F; Tuzcu EM; Peterson ED; Brindis RG; Mack MJ;
    JAMA; 2015 Mar; 313(10):1019-28. PubMed ID: 25756438
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence and Impact of Atrial Fibrillation in Patients With Severe Aortic Stenosis Undergoing Transcatheter Aortic Valve Replacement: An Analysis From the SOURCE XT Prospective Multicenter Registry.
    Tarantini G; Mojoli M; Windecker S; Wendler O; Lefèvre T; Saia F; Walther T; Rubino P; Bartorelli AL; Napodano M; D'Onofrio A; Gerosa G; Iliceto S; Vahanian A
    JACC Cardiovasc Interv; 2016 May; 9(9):937-46. PubMed ID: 27085579
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of pre-existing or new-onset atrial fibrillation on 30-day clinical outcomes following transcatheter aortic valve replacement: Results from the BRAVO 3 randomized trial.
    Hengstenberg C; Chandrasekhar J; Sartori S; Lefevre T; Mikhail G; Meneveau N; Tron C; Jeger R; Kupatt C; Vogel B; Farhan S; Sorrentino S; Sharma M; Snyder C; Husser O; Boekstegers P; Hambrecht R; Widder J; Hildick-Smith D; De Carlo M; Wijngaard P; Deliargyris E; Bernstein D; Baber U; Mehran R; Anthopoulos P; Dangas G;
    Catheter Cardiovasc Interv; 2017 Nov; 90(6):1027-1037. PubMed ID: 28493641
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of cardiovascular mortality, bleeding, vascular and cerebrovascular events in patients with atrial fibrillation vs. sinus rhythm undergoing transfemoral Transcatheter Aortic Valve Implantation (TAVR).
    Herold J; Herold-Vlanti V; Sherif M; Luani B; Breyer C; Bonaventura K; Braun-Dullaeus R
    BMC Cardiovasc Disord; 2017 Dec; 17(1):298. PubMed ID: 29262768
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcomes Following Urgent/Emergent Transcatheter Aortic Valve Replacement: Insights From the STS/ACC TVT Registry.
    Kolte D; Khera S; Vemulapalli S; Dai D; Heo S; Goldsweig AM; Aronow HD; Elmariah S; Inglessis I; Palacios IF; Thourani VH; Sharaf BL; Gordon PC; Abbott JD
    JACC Cardiovasc Interv; 2018 Jun; 11(12):1175-1185. PubMed ID: 29929641
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral Anticoagulant Type and Outcomes After Transcatheter Aortic Valve Replacement.
    Jochheim D; Barbanti M; Capretti G; Stefanini GG; Hapfelmeier A; Zadrozny M; Baquet M; Fischer J; Theiss H; Todaro D; Chieffo A; Presbitero P; Colombo A; Massberg S; Tamburino C; Mehilli J
    JACC Cardiovasc Interv; 2019 Aug; 12(16):1566-1576. PubMed ID: 31202946
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antithrombotic Therapy and Cardiovascular Outcomes After Transcatheter Aortic Valve Replacement in Patients With Atrial Fibrillation.
    Kosmidou I; Liu Y; Alu MC; Liu M; Madhavan M; Chakravarty T; Makkar R; Thourani VH; Biviano A; Kodali S; Leon MB
    JACC Cardiovasc Interv; 2019 Aug; 12(16):1580-1589. PubMed ID: 31439338
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 1-Year Clinical Outcomes in Women After Transcatheter Aortic Valve Replacement: Results From the First WIN-TAVI Registry.
    Chieffo A; Petronio AS; Mehilli J; Chandrasekhar J; Sartori S; Lefèvre T; Presbitero P; Capranzano P; Tchetche D; Iadanza A; Sardella G; Van Mieghem NM; Meliga E; Dumonteil N; Fraccaro C; Trabattoni D; Mikhail G; Sharma S; Ferrer MC; Naber C; Kievit P; Baber U; Snyder C; Sharma M; Morice MC; Mehran R;
    JACC Cardiovasc Interv; 2018 Jan; 11(1):1-12. PubMed ID: 29301640
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Apixaban in Patients With Atrial Fibrillation After Transfemoral Aortic Valve Replacement.
    Seeger J; Gonska B; Rodewald C; Rottbauer W; Wöhrle J
    JACC Cardiovasc Interv; 2017 Jan; 10(1):66-74. PubMed ID: 27916486
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Variation in Antithrombotic Therapy and Clinical Outcomes in Patients With Preexisting Atrial Fibrillation Undergoing Transcatheter Aortic Valve Replacement: Insights From the Society of Thoracic Surgeons/American College of Cardiology Transcatheter Valve Therapy Registry.
    Sherwood MW; Gupta A; Vemulapalli S; Li Z; Piccini J; Harrison JK; Dai D; Vora AN; Mack MJ; Holmes DR; Rumsfeld JS; Cohen DJ; Thourani VH; Kirtane AJ; Peterson ED
    Circ Cardiovasc Interv; 2021 Apr; 14(4):e009963. PubMed ID: 33877866
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of atrial fibrillation after transcatheter aortic valve replacement: Challenges and therapeutic considerations.
    Ammar A; Elbatran AI; Wijesuriya N; Saberwal B; Ahsan SY
    Trends Cardiovasc Med; 2021 Aug; 31(6):361-367. PubMed ID: 32599334
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Left Ventricular Hypertrophy Does Not Affect 1-Year Clinical Outcomes in Patients Undergoing Transcatheter Aortic Valve Replacement.
    Varshney AS; Manandhar P; Vemulapalli S; Kirtane AJ; Mathew V; Shah B; Lowenstern A; Kosinski AS; Kaneko T; Thourani VH; Bhatt DL
    JACC Cardiovasc Interv; 2019 Feb; 12(4):373-382. PubMed ID: 30784643
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stroke and Cardiovascular Outcomes in Patients With Carotid Disease Undergoing Transcatheter Aortic Valve Replacement.
    Kochar A; Li Z; Harrison JK; Hughes GC; Thourani VH; Mack MJ; Matsouaka RA; Cohen DJ; Peterson ED; Jones WS; Vemulapalli S
    Circ Cardiovasc Interv; 2018 Jun; 11(6):e006322. PubMed ID: 29895600
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inclusion of Functional Status Measures in the Risk Adjustment of 30-Day Mortality After Transcatheter Aortic Valve Replacement: A Report From the Society of Thoracic Surgeons/American College of Cardiology TVT Registry.
    Arnold SV; O'Brien SM; Vemulapalli S; Cohen DJ; Stebbins A; Brennan JM; Shahian DM; Grover FL; Holmes DR; Thourani VH; Peterson ED; Edwards FH;
    JACC Cardiovasc Interv; 2018 Mar; 11(6):581-589. PubMed ID: 29566805
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidence, Predictors, and Outcomes of Permanent Pacemaker Implantation Following Transcatheter Aortic Valve Replacement: Analysis From the U.S. Society of Thoracic Surgeons/American College of Cardiology TVT Registry.
    Fadahunsi OO; Olowoyeye A; Ukaigwe A; Li Z; Vora AN; Vemulapalli S; Elgin E; Donato A
    JACC Cardiovasc Interv; 2016 Nov; 9(21):2189-2199. PubMed ID: 27832844
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 57.